Centre of Excellence for Gastrointestinal Inflammation and Immunity Research; Department of Medicine; Department of Public Health Sciences; School of Public Health; University of Alberta; Edmonton, AB Canada.
Gut Microbes. 2013 Nov-Dec;4(6):549-67. doi: 10.4161/gmic.27000. Epub 2013 Nov 6.
Policy analysis shows that H. pylori test and treat strategies targeting adults at moderate to high risk of H. pylori-induced disease is likely to be cost-effective for preventing digestive diseases responsible for a large global disease burden. Little is known, however, about health benefits to children from eliminating this infection. We conducted a systematic review of the evidence regarding health benefits to children from treatment to eliminate H. pylori infection. We systematically searched Ovid MEDLINE for pertinent review articles published through 2012. We excluded reviews focused on treatment efficacy and scrutinized reference lists of selected reviews to identify additional eligible reviews. Fifteen reviews met specified inclusion criteria. Overall, they show that few reported studies investigating pediatric health effects of treatment for H. pylori infection were well designed with adequate statistical power. Thus, there is insufficient evidence for drawing conclusions about health benefits to children from treatment to eliminate H. pylori infection.
政策分析表明,针对中高度感染幽门螺杆菌风险的成年人进行的幽门螺杆菌检测和治疗策略,很可能具有成本效益,可以预防导致全球疾病负担的主要消化疾病。然而,对于消除这种感染对儿童健康的益处却知之甚少。我们对消除幽门螺杆菌感染对儿童健康益处的相关证据进行了系统评价。我们系统地在 Ovid MEDLINE 上搜索了截至 2012 年出版的相关综述文章。我们排除了侧重于治疗效果的综述,并仔细审查了选定综述的参考文献,以确定其他合格的综述。有 15 篇综述符合特定的纳入标准。总体而言,它们表明,很少有研究调查幽门螺杆菌感染治疗对儿科健康的影响,而且这些研究设计良好,具有足够的统计效力。因此,没有足够的证据可以得出关于消除幽门螺杆菌感染对儿童健康有益的结论。